2023 News Briefs - International Neuromodulation SocietyEarlier News:
Breaking NewsArticle Addresses the Value of Vagus Nerve Stimulation and its Trending Presence on Social Media October 29, 2023 - Vagus nerve stimulation (VNS) is gaining popularity as a wellness trend, with claims of various benefits. While it has gained attention on social media, this article indicates that it is essential to understand that VNS is not a cure-all, but does have significant medical applications, such as its approval in treating epilepsy, treatment-resistant depression, and stroke recovery, as well as numerous other conditions where its application is being researched. (Source: The Messenger) Neuromodulation Shows Promise as an Adjunctive Treatment for Postmastectomy Pain Syndrome October 27, 2023 - Neuromodulation, particularly spinal cord stimulation (SCS), shows potential as an effective treatment for postmastectomy pain syndrome (PMPS) in a recent case report, were a PMPS patient experienced significant pain relief and improved quality of life following SCS implantation after other treatments had failed. (Source: Cureus) October 27, 2023 - The CEO of Cognito Therapeutics presented an overview of the company's gamma sensory stimulation device and its potential as a therapy for Alzheimer's disease (AD) patients at the 2023 Clinical Trials on Alzheimer's Disease (CTAD) conference. The device demonstrated promising results in the phase 2 OVERTURE study, including extended time to a decline in AD daily living scores, reduced brain atrophy rates, and a favorable safety profile. (Source: Neurology Live) FDA Grants Conditional MRI Use for Enterra's Stimulation Device to Manage Gastroparesis Symptoms October 26, 2023 - The FDA has granted conditional approval for magnetic resonance imaging (MRI) use with Enterra Medical's implantable electrical stimulation device designed to manage symptoms associated with gastroparesis. The Enterra II system, comprising the Enterra 37800 Neurostimulator and Enterra Therapy 4351-35 unipolar leads, aims to relieve symptoms like nausea and vomiting by delivering electrical pulses to nerves and stomach muscles. (Source: Healio) Study Suggests TDCS Shows Promise in Improving Gait for Multiple Sclerosis Patients October 26, 2023 - A recent study published in Neurology evaluated the impact of transcranial direct current stimulation (tDCS) on balance and gait in multiple sclerosis (MS) patients. The research, which included 11 studies involving 230 MS patients, found that tDCS significantly improved gait functionality compared to control groups. However, it did not have a significant impact on static balance or vary significantly with different tDCS locations. (Physician’s Weekly) October 24, 2023 - A pilot study involving patients with Parkinson's disease has shown that accelerated theta-burst transcranial ultrasound (a-tbTUS) stimulation of the primary motor cortices can increase motor evoked potentials (MEPs), suggesting enhanced motor cortex excitability. (Source: Neurology Live) Transcranial Magnetic Stimulation Shows Promise in Treating Post-Stroke Cerebellar Ataxia October 24, 2023 - A case report from UCLA Health highlights the promising results of using repetitive transcranial magnetic stimulation (rTMS) to manage post-stroke cerebellar ataxia, a condition characterized by impaired coordination and balance. The report details the case of a 58-year-old patient who experienced significant improvements in walking speed, balance, and daily activities following bilateral cerebellar rTMS treatment, underscoring the potential of this innovative approach for addressing ataxia. (Source: UCLA Health) Non-Surgical Deep Brain Stimulation Enhances Memory Accuracy and Potential for Alzheimer's Treatment October 24, 2023 - Researchers at the UK Dementia Research Institute (DRI) have developed a non-surgical deep brain stimulation (DBS) technology based on temporal interference (TI) that can improve memory function. The study, published in Nature Neuroscience, demonstrated the effectiveness of TI in stimulating the hippocampus and enhancing memory accuracy in healthy adults, potentially offering a non-invasive treatment option for Alzheimer's patients in the future. The technology is being trialed in early-stage Alzheimer's patients, aiming to restore normal brain activity and alleviate memory impairment symptoms. (Source: Neuro News) October 23, 2023 - This study investigates the association between frailty and postoperative complications in Parkinson's disease patients undergoing deep brain stimulation (DBS). The findings reveal that patients with moderate and significant frailty levels are at a higher risk of complications. (Source: Cureus) October 20, 2023 - A study investigated the effects of repetitive transcranial magnetic stimulation (rTMS) combined with sertraline in major depressive disorder (MDD) patients with somatic pain. Results showed that the combination therapy led to rapid symptom improvement in depression, pain, and cognitive function, highlighting its effectiveness in treating MDD patients with somatic pain. (Source: Nature) October 20, 2023 - A study demonstrated that transcutaneous auricular vagus nerve stimulation (ta-VNS) can alleviate symptoms in pediatric patients with mild-to-moderate inflammatory bowel disease (IBD). Patients aged 10 to 21 with Crohn's disease (CD) or ulcerative colitis (UC) received ta-VNS targeting the cymba conchae of the external left ear. The study found that ta-VNS led to clinical remission in a portion of patients and significantly reduced fecal calprotectin levels, indicating its potential as a valuable tool for IBD treatment. (Source: Medical Xpress) October 20, 2023 - Two studies from UCLA Health indicate that pupil responses to light may help identify individuals who are more likely to benefit from transcranial magnetic stimulation (TMS) as a treatment for depression. (Source: News Wise) October 20, 2023 - Researchers at EPFL have utilized a non-invasive brain-stimulation technique called "transcranial temporal interference electrical stimulation" (tTIS) to target deep brain structures and improve motor skill learning in healthy older subjects. The study marks the first successful non-invasive modulation of the striatum, a crucial brain region for motor control and learning, offering potential non-invasive treatments for disorders involving deep brain structures. (Source: Mirage News) Non-Invasive Temporal Interference Brain Stimulation Shows Promise for Dementia Treatment October 19, 2023 - Scientists from Imperial College London have conducted a successful human trial using a non-invasive brain stimulation technique known as temporal interference (TI) to stimulate neurons in the hippocampus, which is responsible for memory formation and retrieval. This high-frequency technology aims to improve memory loss and cognitive function in individuals with Alzheimer's disease and other forms of dementia by reviving diseased neurons, potentially offering a safer and more accessible treatment avenue than surgical electrode implantation. (Source: New Atlas) Deep Brain Stimulation Enhances Memory and Promotes Neuron Generation in Rett Syndrome Animal Models October 19, 2023 - A recent study shows that deep brain stimulation (DBS) in a specific brain region improves memory significantly and encourages the generation of new, healthy neurons in mouse models of Rett syndrome. These findings offer promising preclinical evidence for the potential use of DBS as a treatment for Rett syndrome patients, addressing cognitive deficits associated with the condition. (Source: Baylor College of Medicine) Study Finds Accelerated Neurostimulation Treatment Shows Promise in Rapidly Easing Depression October 18, 2023 - A study by BrainsWay reveals that an accelerated treatment regimen using Deep Transcranial Magnetic Stimulation (Deep TMS) for major depressive disorder (MDD) can yield positive results in a shorter timeframe. The research, published in Psychiatry Research, indicates that condensed treatment schedules may achieve response rates comparable to standard protocols, providing potential benefits for patients' schedules and suggesting a more rapid onset of therapeutic effects. (Source: Fierce Biotech) October 18, 2023 - The Stroke Recovery and Rehabilitation Roundtable, organized by the International Stroke Recovery and Rehabilitation Alliance (ISRRA), has outlined its recommendations in a special edition of the International Journal of Stroke, which included guidance around non-invasive brain stimulation technologies for stroke including eliminating barriers for use, closing evidence gaps, and optimizing these treatments for stroke. (Source: NeuroNews) October 17, 2023 - A recent meta-analysis of randomized controlled trials (RCTs) examined the therapeutic efficacy of repetitive transcranial magnetic stimulation (rTMS) in improving cognitive functions in individuals with attention-deficit/hyperactivity disorder (ADHD). The study included five RCTs with a total of 189 participants, both adults and children/adolescents. The results indicated that rTMS was more effective than control groups in enhancing sustained attention and processing speed in patients with ADHD. (Source: BMC Psychiatry) Article Addresses Company's Development of Miniaturized Neurostimulator for Mental Health Treatment October 16, 2023 - Motif Neurotech's technology, the Digitally programmable Over-brain Therapeutic (DOT) implant, measures 9 mm across and uses a novel wireless power transfer method which eliminates the need for batteries. This miniaturized device, resembling a "brain pacemaker," stimulates the brain's prefrontal cortex and aims to treat treatment-resistant depression by restoring healthy circuit activity with minimal side effects. (Source: Medical Design & Outsourcing) October 13, 2023 - The U.S. Food and Drug Administration (FDA) has granted an expanded indication for Boston Scientific's WaveWriter Alpha Spinal Cord Stimulator Systems. This expanded FDA approval now includes the treatment of diabetic peripheral neuropathy of the lower extremities using paresthesia-based stimulation. (Source: Healio) October 13, 2023 - Transcranial direct current stimulation (tDCS) shows promise in curbing drug cravings in individuals with cocaine addiction, but mixed results across outcome measures necessitate further high-quality clinical trials and neuroimaging investigations to gauge its overall effectiveness and mechanisms. Alternative cortical stimulation targets are also being explored to enhance treatment outcomes. (Source: Journal of Clinical Medicine) Study on Vagus Nerve Stimulation Shows Long-Term Efficacy in Treatment-Resistant Depression October 13, 2023 - Two cases of patients with treatment-resistant major drug depression (TR-MDD) treated with Vagus Nerve Stimulation (VNS) surgery have shown significant and lasting improvement in MDD symptoms and quality of life over 15 and 16 years, respectively. (Source: Science Direct) Device Shows Promise in Improving Lower Urinary Tract Symptoms in Multiple Sclerosis October 12, 2023 - Results from a 24-week trial revealed that neuromodulation using the StimRouter system led to significant objective and subjective improvements in refractory lower urinary tract symptoms (LUTS) in patients with multiple sclerosis (MS). This minimally invasive therapeutic option demonstrated potential benefits for individuals with MS experiencing LUTS, with improvements in Overactive Bladder questionnaire symptoms and quality of life scores. (Source: Neurology LIve) October 12, 2023 - This case study highlights the successful management of chronic facetogenic axial neck pain using cervical medial branch peripheral nerve stimulation (PNS). The patient experienced significant pain relief and improved functionality after traditional treatments had failed. (Source: Cureus) FDA Approves Company's Next-Gen Intrathecal Drug Delivery System October 10, 2023 - Medtronic has received FDA approval for its SynchroMed III intrathecal drug delivery system, designed to treat chronic pain, cancer pain, and severe spasticity. This targeted drug delivery system delivers medication directly to the spinal cord fluid, offering improved programming efficiency, firmware updates post-implant, enhanced cybersecurity, and compatibility with Medtronic's Control Workflow to reduce systemic opioid use. The system is set to be commercially available later this year. (Source: Drug Delivery Business News) New Research on Deep Brain Stimulation Suggests Potential for Improved Depression Treatment October 10, 2023 - Researchers have identified potential biomarkers for deep brain stimulation (DBS). By monitoring the brain activity of patients undergoing DBS, the researchers found patterns in electrical activity changes that could serve as objective markers for treatment effectiveness, with potential to guide treatment decisions and intervene before relapses occur. (Source: Inquirer) NIH Grant Funds Parkinson's Research Using Video Games in Deep Brain Stimulation Surgery October 10, 2023 - A $5 million grant from the National Institutes of Health (NIH) is supporting a five-year research project that aims to gain insights into Parkinson's disease by having patients play video games during deep brain stimulation (DBS) surgery. Researchers will study how the brain regulates movement, decision-making, and action control, and data collected will also help build a mathematical model of the brain's function. (Source: University of California - Riverside) Device Proves Effective in Chronic Pain Treatment October 7, 2023 - Biotronik Neuro has shared positive results from the BENEFIT-02 trial, the first clinical evaluation of a multiphase stimulation paradigm, which supports the effectiveness of RESONANCE multiphase stimulation used in Biotronik's Prospera spinal cord stimulation (SCS) system for chronic pain treatment. The study demonstrated that RESONANCE requires less power and delivers a distributed therapeutic pulse pattern across the spinal cord, improving pain relief, sleep quality, and physical activity. (Source: NeuroNews International) Closed Loop Spinal Cord Stimulation Therapy Demonstrates Long-Term Pain Relief October 5, 2023 - A study published in Regional Anesthesia and Pain Medicine demonstrated that evoked compound action potentials (ECAP)-controlled closed-loop spinal cord stimulation (CL-SCS) therapy provided sustained and durable pain relief over 36 months compared to open-loop SCS. (Source: Neurology Advisor) Company Utilizes Spinal Cord Stimulation and Brain-Computer Interface to Restore Movement October 5, 2023 - Onward is pioneering a combination of spinal cord stimulation (ARC-IM) and brain-computer interface (BCI) technology to restore thought-driven movement in individuals with spinal cord injuries. The BCI captures the intention to move, decodes it with artificial intelligence, and converts it into ARC-IM therapy for precise spinal cord stimulation, resulting in thought-driven movement. Onward recently performed the first human implant of this technology. The company aims to assess the value of BCI augmentation and potentially commercialize the therapy by the end of the decade. (Source: Mass Device) NANS Leads Multi-Society Response to SCS Review in Washington State October 4, 2023 - The North American Neuromodulation Society (NANS) has spearheaded a collaborative response, joined by the Multisociety Pain Workgroup (MPW), to address the allegedly flawed review of spinal cord stimulation (SCS) evidence by the Washington State Health Care Authority (WSHCA). The review's methodology has been criticized, and NANS is advocating for extending SCS coverage for patients in the state. (Source: NeuroNews) Company Initiates Trial for Brain-Computer Interface Device to Aid ALS Patients October 3, 2023 - Neuralink has commenced enrollment for the PRIME study, a first-in-human trial of its brain-computer interface (BCI) technology. The trial aims to evaluate the safety and efficacy of Neuralink's implantable BCI, surgical robot, and BCI software in enabling individuals with quadriplegia due to ALS or spinal cord injury to control external devices using their thoughts. The study will involve surgical implantation of BCI devices with over 1,000 tiny electrodes to decode brain signals, allowing participants to control a computer cursor or keyboard. The research will span six years, including an 18-month primary study followed by long-term data collection. (Source: ALS News Today) October 1, 2023 - This study investigates the impact of extracellular electric fields (EFs) on thalamic reticular nucleus (TRN) neurons, shedding light on their potential role in deep brain stimulation (DBS) for epilepsy treatment. The research explores how EFs affect the firing patterns of TRN cells under different neuronal states. The findings reveal that EFs have state-dependent effects, influencing the timing of action potentials and burst discharges in TRN neurons. (Source: Nature) September 30, 2023 - Researchers found that the combination of dark chocolate consumption and concurrent dual-site transcranial direct current stimulation (a-tDCS) significantly improved cognitive performance during and after endurance exercise in hypoxia, leading to a 45% increase in time-to-exhaustion compared to control conditions, potentially offering athletes a powerful strategy to counter the detrimental effects of hypoxia and mental fatigue. (Source: Nature) September 29, 2023 - Recent developments in brain-computer interface (BCI) technology offer hope for restoring mobility and function in patients with neurological disorders. While these breakthroughs show potential, experts caution that challenges remain, especially for conditions like stroke, highlighting the complexity of interpreting brain signals and the gradual path towards clinical adoption, with potential clinical effects still years away. (Source: NeuroNews International) September 28, 2023 - A study conducted by medical researchers from various Chinese institutions has revealed that the placebo effect appears to be growing stronger in trials of transcranial magnetic stimulation (TMS) therapy for depression. The researchers analyzed data from two separate trials conducted over different time periods, finding that the placebo effect exhibited greater efficacy in the more recent trial, potentially due to increased patient belief in the therapy's effectiveness. (Source: Medical Xpress) September 25, 2023 - A study aimed at assessing the effectiveness of vagus nerve stimulation (VNS) in children aged six and younger with drug-resistant generalized epilepsy (DRGE) has shown promising results. The research involved a novel scoring system, in addition to the McHugh Classification System, to evaluate the outcome of VNS treatment, with a total response rate of 91.67%, and it highlighted the potential benefits of VNS in reducing seizure frequency and improving the quality of life for these young patients. Further investigation is needed to understand the long-term efficacy of VNS. (Source: Physicians Weekly) September 25, 2023 - A recent case report highlights the potential of transcranial magnetic stimulation (TMS) as a treatment for bipolar II disorder. The report discusses a 35-year-old male patient who, after undergoing TMS treatment, experienced significant improvements in depressive symptoms and cognitive function, emphasizing the potential benefits of TMS in managing bipolar disorder. (Source: Cureus) September 25, 2023 - A recent longitudinal study has explored the potential of maintenance repetitive transcranial magnetic stimulation (rTMS) therapy in preventing relapse/recurrence of major depressive disorder (MDD). The study, which enrolled 300 MDD patients, found that maintenance rTMS therapy could be an effective and safe approach to reduce the risk of depressive relapse/recurrence over a 12-month period, offering hope for improved MDD management. (Source: Physician’s Weekly) Device Offers Non-Invasive Brain-Computer Interface Without Open Surgery September 24, 2023 - Synchron has developed the Synchron Switch, a brain-computer interface (BCI) that can be inserted into the brain without open surgery. Utilizing existing medical technologies like stents and catheters, this wireless BCI, currently in clinical testing, enables users to control devices by thinking about moving parts of their bodies, offering potential benefits for individuals with conditions like ALS and paralysis. (Source: CNET) September 22, 2023 - Researchers from the University of Missouri School of Medicine have conducted a study suggesting that theta burst transcranial magnetic stimulation (TBS) could be a potential treatment for nicotine dependence by enhancing self-control and reducing cravings. The study involved 37 participants and demonstrated that both continuous and intermittent TBS to the right inferior frontal gyrus improved inhibitory control and decreased cravings and smoking, offering potential therapeutic implications for substance use disorders. (Source: HMP Global Learning Network) September 22, 2023 - Researchers from the University of Missouri School of Medicine conducted a study using a brain-machine interface in head-fixed mice to investigate the impact of spatiotemporal dynamics of distributed artificial stimulation feedback. They found that mice could efficiently learn to control a virtual cursor when the optogenetic feedback pattern was spatially and temporally contiguous, highlighting the importance of feedback organization in brain-machine interfaces. (Source: Science) Company's SCS Therapy Proves Cost-Effective in Treating Painful Diabetic Neuropathy and Back Pain September 22, 2023 - Nevro Corporation has released new data demonstrating the health economic benefits of its proprietary 10kHz spinal cord stimulation (SCS) therapy for painful diabetic neuropathy (PDN) and non-surgical refractory back pain (NSRBP). The study results showed that the 10kHz therapy significantly reduced healthcare costs and improved the quality of life for patients with these conditions. (Source: Neuronews International) Article Addresses Science Behind Deep Brain Stimulation for Depression September 21, 2023 - Recent advancements in brain imaging technology are enabling researchers to target specific areas of the brain with deep brain stimulation (DBS) to treat depression more precisely. This article discusses the experiences of individuals who underwent DBS for depression and highlights the role of brain imaging in determining the optimal stimulation targets. Researchers have identified brain regions like the subcallosal cingulate (SCC) and the ventral capsule/ventral striatum (VC/VS) as potential targets for DBS. Personalizing the technique and tailoring electrical patterns to each patient's unique needs is a growing focus of research in the field. Clinical trials are underway to better understand how different types of stimulation affect the brain and to develop personalized DBS treatments for depression. (Source: Science News) Article Addresses What it's Like to Live with Deep Brain Stimulation for Depression September 21, 2023 - Living with deep brain stimulation (DBS) for depression involves both physical and emotional challenges for patients. This article shares the experiences of individuals who have undergone DBS treatment for depression and discusses the physical aspects of the procedure, such as having battery packs implanted in the chest, wires under the skin, and external electrodes. Patients also describe their emotional journey, including the need to relearn how to cope with emotions after living with severe depression. (Source: Science News) September 21, 2023 - Transcranial direct current stimulation (tDCS) has shown promise in improving speech for individuals with subacute aphasia. In a study involving 58 participants, researchers found that tDCS treatment resulted in speech improvement as early as 1 week, with significant changes observed at 5 weeks compared to a sham treatment. Aphasia patients often require extensive speech therapy, and tDCS could potentially enhance the efficiency and effectiveness of therapy. The study also highlighted the positive impact of tDCS on improving descriptive powers in individuals with aphasia, making their communication skills more applicable in social settings. (Source: HEALIO) Deep Brain Stimulation Shows Promise for Cognitive Improvement in Treatment-Resistant Depression September 20, 2023 - A systematic review and meta-analysis of studies on deep brain stimulation (DBS) in treatment-resistant depression (TRD) found that, while there were no significant cognitive changes within the first 6 months of DBS treatment, TRD patients experienced small to moderate improvements in verbal memory, visual memory, attention/psychomotor speed, and executive functioning between 6 and 18 months of treatment. Not enough studies were available for meta-analysis of effects after 18+ months of DBS, nor for an active and sham DBS comparison. (Source: Nature) September 20, 2023 - A study published in Nature describes the use of deep brain stimulation (DBS) in patients with treatment-resistant depression (TRD). The research introduces an objective biomarker for tracking depression recovery, leveraging advances in electrophysiology monitoring, artificial intelligence, and facial expression analysis. The biomarker aids in distinguishing periods of normal transient distress from those requiring intervention, providing insights into the complex relationship between brain dynamics and depressive disorders. (Source: Nature) September 19, 2023 - Neuralink, a brain-implant startup, has received approval from an independent review board to commence recruiting patients for its inaugural human trial. The study aims to involve individuals with paralysis in a six-year investigation to test the company's experimental brain-computer interface (BCI) device. Neuralink's previous animal testing faced criticism, triggering investigations into alleged animal abuse and mishandling of biohazardous materials, but the company is moving forward with its pursuit of developing a BCI that enables users to control a computer using their thoughts. (Source: The Guardian) Depressive Symptom Dimensions May Predict rTMS Treatment Outcomes for Post-Stroke Depression September 19, 2023 - A study explores the potential of repetitive transcranial magnetic stimulation (rTMS) for post-stroke depression (PSD) treatment. In a randomized controlled trial involving three rTMS target groups, researchers found that the left dorsolateral prefrontal cortex (DLPFC) group exhibited significantly different depression scores from the other groups at various treatment intervals. The study suggests that specific depressive symptom dimensions, such as mood and neurovegetative scores, can predict the effectiveness of rTMS treatment for PSD, with left DLPFC high-frequency rTMS showing promise in alleviating depressive symptoms in subacute subcortical ischemic stroke patients. (Source: Physicians Weekly) Study Suggests Vagus Nerve Stimulation Shows Promise in Improving Motor Function After Stroke September 18, 2023 - A systematic review and meta-analysis have revealed that vagus nerve stimulation (VNS), whether invasive or non-invasive, can significantly enhance motor function and reduce motor impairment in stroke patients. This approach provides hope for stroke survivors, particularly those with severe impairments, by offering a potential means of improving upper limb function. (Source: Nature) Company Expands CE Mark Approval for Exablate Neuro to Treat Essential Tremors on Both Sides September 15, 2023 - Insightec Ltd. has received an extended CE mark approval for its Exablate Neuro focused ultrasound platform, allowing patients with essential tremors to receive treatment on both sides of their body. This expansion aims to provide full-body relief from tremors, enabling patients to regain their ability to carry out everyday activities. (Source: Bioworld) Company Initiates Early Feasibility Study for Non-Invasive Neuromodulation Device in ALS Patients September 15, 2023 - PathMaker Neurosystems has initiated an early feasibility study to assess its non-invasive neuromodulation device, MyoRegulator, in patients with amyotrophic lateral sclerosis (ALS). The device, designed to suppress motor neuron hyperexcitability via skin pads, aims to provide an alternative treatment option for ALS, a progressive neurodegenerative disease with limited pharmaceutical interventions. (Source: Medical Device Network) Deep Brain Stimulation During Sleep Enhances Memory Consolidation in Epilepsy Patients September 14, 2023 - A study published in Nature Neuroscience reveals that targeted deep-brain stimulation during a specific sleep stage improves memory consolidation in epilepsy patients. Researchers used a closed-loop system to synchronize brain activity between the hippocampus and cortex using electrical pulses during sleep, leading to enhanced memory performance. This study offers insights into memory mechanisms and potential applications for memory disorders like Alzheimer's. (Source: AJMC) Thin-Film Neural Electrodes for Enhanced Brain Monitoring and Stimulation September 14, 2023 - Researchers at Tokyo Institute of Technology have developed flexible thin-film neural electrodes designed to match the mechanical properties of brain tissue, improving electrocorticography (ECoG) recordings and targeted neural stimulation. These electrodes, made from polystyrene-block-polybutadiene-block-polystyrene (SBS) and gold nanoink, conform accurately to the brain's irregular ridges. Experiments on epilepsy rat models demonstrated their potential for precise neural measurements, visualization of seizure activity, and stimulation of various brain regions without causing inflammation or adverse effects. (Source: Eureka! Alert) September 14, 2023 - A study conducted among medical students at Umm Al-Qura University in Saudi Arabia has highlighted a significant lack of knowledge regarding neuromodulation (NM) devices. The research aimed to assess the knowledge and perception of NM devices among undergraduate medical students and found that both pre-clinical and clinical-year students exhibited insufficient knowledge. The study suggests the need for comprehensive education on NM devices to ensure optimal patient care and early referrals for treatment. (Source: Cureus) Study Finds Device Shows Promise in Relieving Symptoms for Teens with Painful GI Disorders September 13, 2023 - NeurAxis, formerly known as Innovative Health Solutions, has conducted a study demonstrating that its IB-Stim neuromodulation device can effectively alleviate pain in teenagers with disorders of the gut-brain interaction (DGBIs) such as irritable bowel syndrome (IBS). The study involved 31 patients aged 11 to 18 and showed significant reductions in abdominal pain, nausea, functional disability, and somatization after four weeks of treatment with IB-Stim. While self-reported quality of life scores didn't show a statistically significant change, parents observed marked improvements in their children's physical and psychosocial function. (Source: Fierce Biotech) Focused Ultrasound Opens Blood-Brain Barrier for Potential Alzheimer's Treatment September 13, 2023 - Two new studies by researchers from Columbia University have demonstrated the use of non-invasive focused ultrasound (FUS) to open the blood-brain barrier (BBB), potentially offering a non-invasive method to treat neurodegenerative diseases like Alzheimer's. In the first study, FUS and microbubbles allowed the delivery of CRISPR gene-editing technology to mouse neurons with over 25% editing efficiency, suggesting potential gene corrections for Alzheimer's disease. In the second study, FUS alone triggered an immune response in mice's brains, reducing beta-amyloid and tau loads, two proteins linked to Alzheimer's, and improving working memory. (Source: New Atlas) Instagram Posts About Spinal Cord Stimulation Analyzed for Health Information September 12, 2023 - A study conducted on Instagram posts related to spinal cord stimulation (SCS) revealed that medical practitioners and organizations dominate the platform, with 24% of posts coming from individual accounts sharing personal experiences. Medical practitioners' posts were primarily educational, while patients focused on their experiences. The study suggests using hashtags like #MedEd to make educational content more accessible and highlights the need for reliable medical information on social media platforms. (Source: Cureus) September 12, 2023 - Abbott has issued an urgent medical device correction for over 197,000 of its implanted neuromodulation systems, which includes spinal cord stimulators and a deep brain stimulator. The correction comes after reports that some devices failed to restart after exiting the "MRI mode," meant to temporarily disable therapy during imaging scans. The issue, which has received a Class I rating from the FDA, is related to Bluetooth pairing problems between the implantable pulse generator and the Patient Controller app, either due to user actions or software updates. Abbott has updated device instructions and app notifications to address the problem, and additional surgeries have been required in about half of the reported cases. The company didn't disclose the exact number of complaints or whether any injuries occurred but noted an incidence rate of around 0.06% of all distributed devices. (Source: Fierce Biotech) AI-Powered Brain Implant Restores Speech to Paralyzed Stroke Survivor September 10, 2023 - After nearly two decades of being unable to speak due to a brain stem stroke, Ann Johnson becomes the first patient to successfully use an AI-driven brain implant that decodes her brain signals, allowing her to communicate through a computer-generated avatar that synthesizes speech and facial expressions. Researchers at the University of California San Francisco and the University of California Berkeley achieved this breakthrough. (Source: Business Insider) Article Addresses Unlocking Health Benefits through Vagus Nerve Stimulation September 10, 2023 - The article highlights the therapeutic potential of vagus nerve stimulation in addressing diverse health issues like depression, obesity, alcoholism, and inflammation. Various methods, such as cold exposure and controlled breathing, are discussed as means to stimulate the vagus nerve. Research explores its impact on conditions like epilepsy, arthritis, Crohn's disease, and obesity. (Source: Newstalk) Article Addresses Transcranial Magnetic Stimulation as a Growing Therapy for Depression and Beyond September 10, 2023 - Transcranial magnetic stimulation (TMS) is gaining traction as a treatment for depression, with promising results in clinical trials. Additionally, research explores its potential effectiveness in addressing conditions like OCD, addiction disorders, chronic pain, autism, and ADHD. Challenges include the need for daily clinic visits and potential limitations in Medicare funding for maintenance treatments. (Source: PsyPost) September 8, 2023 - A study published in Nature Neuroscience suggests that targeted deep-brain stimulation during specific sleep phases can improve memory consolidation in epilepsy patients. The research reveals the interaction between the memory hub and the cortex and opens possibilities for memory enhancement in individuals with disorders like Alzheimer's disease. (Source: NeurologyLive) Clinical Review Discusses Use of Neuromodulation Techniques During Pregnancy and Lactation September 8, 2023 - This clinical review explores the management of epilepsy in pregnant and lactating women, particularly emphasizing the role of neuromodulation techniques. It discusses the safety and effectiveness of treatments like vagal nerve stimulation, responsive neurostimulation, and deep brain stimulation in this population, alongside antiseizure medications. (Source: BMJ) Transcranial Stimulation Study Shows Promise in Treating Consciousness Disorders After Brain Injury September 6, 2023 - Published in the European Journal of Neurology, an international study led by the University of Liège has tested transcranial direct current stimulation (tDCS) on patients with consciousness disorders following severe brain injuries and reports promising results at the three-month follow-up. (Source: EurekaAlert!) Six U.S. Patients Receive Brain-Computer Interface Implant in Company's Feasibility Study September 6, 2023 - Synchron has successfully implanted its brain-computer interface device in six patients as part of its U.S.-based feasibility study. The device aims to restore functioning for patients with severe paralysis. Results from the study are expected to be available next year. (Source: MedTech Dive) Company Receives CE Mark for Closed-Loop Spinal Cord Stimulator September 6, 2023 - Medtronic has been granted a CE mark for its Inceptiv closed-loop rechargeable spinal cord stimulator (SCS). The device incorporates closed-loop therapy with evoked compound action potentials (ECAPs) to continuously sense the body’s neural response to stimulation and automatically adjust spinal cord stimulation levels in real-time, providing consistent therapy for patients during various activities. The system offers full-body MRI access and is expected to be available in Europe soon. (Source: Medical Device and Diagnostic Industry) Brain Stimulation Aids Stroke Patients in Small Trial September 5, 2023 - A small clinical trial conducted by researchers at the Cleveland Clinic used deep brain stimulation (DBS) in combination with physical therapy to improve upper limb function in stroke patients. The trial involved 12 participants with moderate to severe upper limb impairment post-stroke. Results showed that the DBS and physical therapy combination was safe and improved motor function in nine of the participants, with better outcomes in those with retained motor function in the hand. (Source: National Institutes of Health) Meta-Analyses Suggest Intrathecal Drug Delivery Effective for Managing Cancer-Related Pain September 5, 2023 - Recent systematic reviews and meta-analyses have provided evidence that intrathecal drug delivery (IDD) systems are an effective approach for managing cancer-related pain and patients may benefit from its increased application. The reviews show a significant reduction in pain intensity and opioid consumption among cancer patients who received IDD, with minor complications reported, suggesting the potential for safer and more efficient pain relief. (Source: NeuroNews) September 5, 2023 - Preoperative functional MRI (fMRI) plays a crucial role in improving surgical outcomes for patients with brain tumors. This technique aids in planning surgical approaches, preserving essential brain functions, and reducing adverse events during surgery. This review suggests that while the clinical benefits of fMRI in neuro-oncology are well-established, ongoing research would benefit from focusing on addressing challenges, such as neurovascular uncoupling and harnessing artificial intelligence. (Source: RSNA) September 5, 2023 - Amber Therapeutics, a startup spin out of the University of Oxford, has acquired bioinduction, a UK-based company known for its Picostim DyNeuMo platform. This platform was initially designed for deep brain stimulation in Parkinson’s disease and has been integrated into neuromodulation systems like Amber’s. The company aims to accelerate its development and build a broader neurostim technology portfolio. (Source: Fierce Biotech) Article Investigates Vagus Nerve Stimulation's Effect on Aldosterone Levels September 4, 2023 - A recent study examined the impact of acute transcutaneous vagus nerve stimulation (tVNS) on serum aldosterone levels, a mineralocorticoid hormone linked to cardiovascular injuries and hypertension. The study found that while tVNS reduced aldosterone levels in younger and older adults, the difference was not significant enough to draw relevant conclusions. Aldosterone levels were influenced by age and sex, as well, irrespective of tVNS. (Source: News Medical) Study Reveals Insights About Brain's Locomotion Control Center Through Nerve Stimulation September 4, 2023 - Researchers uncovered key mechanisms in the brain that control the initiation of movement. The mesencephalic locomotor region (MLR) found in various vertebrates plays a crucial role in initiating movements like walking, flying, and swimming. Using zebrafish larvae brains, the study observed and mapped the neural circuits responsible for triggering forward motion and found that stimulation intensity correlates with vigor of movement. This discovery holds potential for understanding and addressing motor deficiencies, particularly in conditions like Parkinson’s disease (Source: Neuroscience News) Article Addresses Patient's Experience with Deep Brain Stimulation for Essential Tremor September 1, 2023 - A patient underwent deep brain stimulation (DBS) to alleviate the debilitating effects of essential tremor which had affected her for 37 years. After the procedure, the patient experienced significant improvements in hand function, enabling better performance in everyday tasks and some improvement in speech. (Source: Froedtert) September 1, 2023 - A 62-year-old woman who had been suffering from painful spasticity for 15 years following an ischemic stroke underwent intrathecal baclofen infusion pump (IBIP) therapy, achieving significant pain relief and partial spasticity improvement. (Source: Cureus) Study Suggests Brain Stimulation Through Electrodes Could Enhance Mathematical Learning August 31, 2023 - Researchers from multiple universities, including Surrey, Oxford, and Radboud, have explored the potential of neurostimulation using high-frequency random noise stimulation (tRNS) delivered through electrodes on the scalp to improve mathematical skills, particularly in individuals who struggle with math. The study found that this neurostimulation could enhance learning outcomes, particularly for those with lower brain excitability. (Source: The Independent) Study Finds Vagus Nerve Stimulation Reduces Serum Aldosterone Levels in Women as They Age August 30, 2023 - A recent randomized study examined the effects of transcutaneous vagus nerve stimulation (tVNS) on serum aldosterone levels in healthy participants of different age groups. While aldosterone levels decreased post-stimulation in both younger and older participants, the study revealed a significant interaction between sex and age, with younger women having the highest mineralocorticoid levels and older females showing the lowest. (Source: Nature) Two-Year Data Confirms Long-Term Efficacy of Company's SCS Therapy for Painful Diabetic Neuropathy August 30, 2023 - Nevro Corporation has published two-year data from the SENZA painful diabetic neuropathy (PDN) trial, revealing the long-term effectiveness of high-frequency 10kHz spinal cord stimulation (SCS) for treating refractory PDN. The study found that patients who received a 10kHz SCS implant alongside conventional medical management experienced lasting pain relief, improved quality of life, and sleep at 24 months post-implantation. (Source: NeuroNews) Repairing Broken Brain Circuits Offers New Potential for Parkinson's Disease Treatment August 30, 2023 - Researchers are exploring the potential of repairing dysfunctional brain circuits to treat Parkinson's disease, with a focus on the interaction between the thalamus and the cortex. They found a significant reduction in connectivity in a specific subtype of cortical neurons in a Parkinson's state. Designer receptors activated by designer drugs (DREADDs) were used to manipulate nerve cell activity in animal models and partially restored connectivity between the thalamus and the cortex. (Source: Advanced Science News) Personalized Transcranial Neuromodulation Holds Promise for Chronic Pain Management August 30, 2023 - Researchers have explored ways to personalize repetitive transcranial magnetic stimulation (rTMS) for individuals with treatment-resistant chronic pain. A retrospective study reviewed scientific publications and found various methods for customizing cortical neuromodulation, including prediction-based rTMS, altering stimulation patterns, targeting non-motor areas, adjusting based on cortical networks/rhythms, deep sensory profiling, and tailoring motor rTMS specifics. (Source: Physicians Weekly) Ischiorectal Approach Simplifies Cryoablation for Two Pudendal Neuralgia Cases August 30, 2023 - In a dual case report, the authors describe a novel ischiorectal approach to cryoablation of the pudendal nerve using a handheld device. This approach offers a simplified and safe method for targeting the pudendal nerve, providing sustained pain relief for both patients with pudendal neuralgia, albeit one patient achieved major pain reduction for significantly longer and the other experienced delayed onset. (Source: Cureus) Advancements in Transcranial Magnetic Stimulation to Personalize Chronic Pain Treatment August 30, 2023 - In a study published in the August 2023 issue of Pain, researchers explore the potential of personalized repetitive transcranial magnetic stimulation (rTMS) for treating chronic pain. Through a systematic review of scientific literature, they identify various approaches to customize cortical neuromodulation, including prediction-based rTMS, altering stimulation patterns, targeting non-motor areas, and adjusting based on cortical networks/rhythms. (Source: Physicians Weekly) August 29, 2023 - Two recent studies featured in Nature demonstrate how advanced brain-computer interfaces (BCIs) empowered by artificial intelligence can decode brain signals and enable paralyzed individuals to regain their ability to speak. These BCIs directly convert brain activity related to attempted speech into audible speech, allowing users to communicate through a digital avatar. (Source: Everyday Health) Article Addresses Noninvasive Vagus Nerve Stimulation to Alleviate Pain in Systemic Sclerosis August 29, 2023 - In a study published in RMD Open, noninvasive therapy called transcutaneous auricular vagus nerve stimulation (tVNS) showed potential to safely reduce pain in individuals with systemic sclerosis (SSc). The study observed reduced pain levels and lower IL-6 (an inflammatory molecule) levels in SSc patients who used tVNS. (Source: Scleroderma News) August 28, 2023 - A diaphragm pacing system played a crucial role in the recovery of a Sacramento woman who had been paralyzed in a horseback riding accident. (Source: ABC) Article Addresses Transcranial Magnetic Stimulation for Various Mental Health Conditions August 29, 2023 - Transcranial Magnetic Stimulation (TMS) has gained attention as a promising treatment for depression, but its potential extends to other mental health conditions. TMS involves the application of magnetic pulses to the brain's nerve cells, with proven effectiveness in treating depression. Research is exploring its application in conditions like Obsessive-Compulsive Disorder (OCD), addiction disorders, chronic pain, autism and Attention Deficit Hyperactivity Disorder (ADHD). (Source: Medical Xpress) Article Addresses Deep Brain Stimulation Combined with Therapy for Stroke Recovery August 29, 2023 - Research from the Cleveland Clinic reveals that deep brain stimulation (DBS) combined with physical therapy can significantly improve the quality of life and independent functioning of stroke patients, even years after their initial stroke. This study marks the first evidence of DBS effectively enhancing brain function post-stroke. (Source: Cleveland.com) Company Initiates Trial to Address Cognitive Dysfunction in Long Covid Patients August 29, 2023 - Soterix Medical has launched the Phase II RECOVER-NEURO clinical study, collaborating with NYU Langone Health's remotely supervised (RS) tDCS program. This trial, part of the Researching COVID to Enhance Recovery (RECOVER) Initiative led by the National Institutes of Health (NIH), aims to address cognitive issues associated with long Covid, such as brain fog, memory problems, and attention difficulties. The study will involve interventions, including Posit Science's cognitive training program, goal management training from Mount Sinai Health System, and Soterix Medical's home-based tDCS system. The trial will assess up to 315 participants and seeks to develop a long Covid treatment based on digital therapy and Soterix Medical's REMOTE-tDCS platform. (Source: Medical Device Network) August 29, 2023 - The BRAINSTORM project, a pan-European effort to develop an innovative treatment for neurological disorders, involves creating injectable magnets that could restore damaged neurons in patients' brains, potentially addressing conditions like depression, epilepsy, and Alzheimer's. (Source: newsd) August 26, 2023 - A comprehensive meta-analysis compared the effects of deep brain stimulation (DBS) in two target regions, subthalamic nucleus (STN) and globus pallidus internus (GPi), on mood and quality of life in Parkinson's disease (PD) patients. The analysis of 14 studies involving 1,088 patients showed that GPi stimulation led to greater improvements in mood and quality of life, as measured by various scales, compared to STN stimulation. However, STN stimulation exhibited advantages in reducing motor symptoms and medication usage, highlighting the complex trade-offs between these two DBS targets for PD treatment. (Source: Cureus) August 24, 2023 - A collaborative study featured in Brain Stimulation reveals a promising breakthrough in the field of neuromodulation. Researchers, led by Michael Jacob Kahana at the University of Pennsylvania, applied targeted electrical stimulation to epilepsy patients with traumatic brain injuries, resulting in a 19% improvement in word recall memory. This innovative approach is guided by biomarkers and individual brain wiring. (Source: NeuroNews) Company Implants Innovative Neuromodulation Device for Migraine and Cluster Headache Relief August 24, 2023 - Salvia BioElectronics has successfully implanted its paper-thin neuromodulation device to treat severe migraine and cluster headaches, marking a significant development in headache treatment. The device, granted FDA breakthrough device designation in 2020, uses thin bioelectronic foils to deliver electrical pulses, offering relief by restoring brain balance. (Source: Medical Device Network) Swine Model Study Explores Immediate Electromagnetic Field Stimulation's Impact on Cortical Injury August 19, 2023 - Researchers have investigated the effects of immediate electromagnetic field (EMF) stimulation on cortical injury using a swine model. The study utilized proprietary non-contact induction sensors and an electromagnetic shielded helmet to measure EMF patterns in Yucatan mini-pigs with traumatic brain injury (TBI). The results showed that early EMF stimulation led to recovery in neuronal circuit-driven electromagnetic field patterns and increased viability of neurons. (Source: Cureus) August 19, 2023 - Researchers have developed a method to address the challenge of acoustic coupling through hairs in transcranial-focused ultrasound (tFUS) procedures by utilizing oil as a coupling medium. In a study involving mice, the technique was compared to traditional methods of coupling through hair shaving and ultrasound gel application. The results demonstrated that the "oil + hairs" approach effectively improved acoustic coupling without trapping air bubbles and achieved comparable outcomes in blood-brain barrier opening to the "ultrasound gel + no hair" group, highlighting the potential for more patient-friendly tFUS procedures without the need for hair shaving. (Source: Nature) Deep Brain Stimulation Shows Promise to Treat Motor Issues Due to Stroke August 18, 2023 - A phase 1 clinical trial testing deep brain stimulation in human stroke survivors shows promise in enhancing upper limb mobility. The trial combined deep brain stimulation with physiotherapy and found that the intervention was safe and led to improved movement in the upper limbs of individuals with moderate-to-severe upper-extremity impairment. (Source: MedicalNewsToday) Article Addresses Promise of Vagal Nerve Stimulation for Stroke Patients August 17, 2023 - A study with stroke patients found significant motor improvement using transcutaneous auricular vagus nerve stimulation. It offers a less invasive alternative to implanted devices and may improve the quality of life for stroke survivors. (Source: Forbes) August 17, 2023 - In a study published in the Journal of Neuroscience, researchers applied phasic transcutaneous auricular vagus nerve stimulation (taVNS) during cognitive tasks, demonstrating its ability to modulate behavioral, pupillary, and electrophysiological responses linked to the noradrenergic system. The study also introduced the pupillary light reflex as a potential biomarker for taVNS efficacy. (Source: Journal of Neuroscience) Company's Neuromodulation System for Incontinence Receives FDA De Novo Clearance August 17, 2023 - BlueWind Medical has gained de novo clearance from the FDA for its neuromodulation system, Revi, designed to treat urge urinary incontinence (UUI). The system combines an ankle-worn wireless device with a small implanted device near the ankle, stimulating the tibial nerve to alleviate UUI symptoms. The clearance was based on positive results from the Oasis trial, with over three-quarters of participants experiencing reduced urge incontinence episodes. The system demonstrated high compliance rates and mild to moderate adverse effects. (Source: Fierce BioTech) August 16, 2023 - Researchers in Japan have demonstrated the potential of transcranial electrical stimulation (TES) to alleviate the distinct walking difficulties associated with Parkinson's disease, known as "Parkinsonian gait." By delivering a low electric current to stimulate the cerebellum on the side of the body with severe symptoms, the treatment group in a study showed significant improvements in walking speed, step length, and gait symmetry, along with reduced freezing of gait. (Source: FreeThink) July 8, 2023 - A study conducted on 1000 individuals found that using binaural beats brain stimulation during cognitive tasks at home significantly deteriorated test scores, contradicting the belief that it enhances cognitive function, while silence or other sounds had no effect. The findings suggest that home-use binaural beats brain stimulation may have reverse effects, weakening rather than supporting cognitive activities. (Source: Nature) Company Launches Advanced FDA-Cleared Transcranial Magnetic Stimulation System in UK July 7, 2023 - Magstim's FDA-cleared Horizon 3.0 transcranial magnetic stimulation (TMS) system is now available for sale in the UK, empowering physicians to advance the treatment of depression, OCD, and anxious depression with non-invasive brain stimulation, as shown by positive patient responses and over 16,000 published studies using Magstim technology. (Source: Yahoo! Finance) July 7, 2023 - A study conducted in Saudi Arabia has found that almost half of the medical students surveyed displayed poor knowledge and unfavorable attitudes towards deep brain stimulation (DBS). The study highlights the need to improve DBS education in medical curricula to ensure future patients have access to this effective therapeutic option. (Source: Cureus) New Study Links Long COVID Symptoms to Vagus Nerve Damage July 7, 2023 - A study conducted in Spain on individuals experiencing Long COVID symptoms revealed that two-thirds of them reported symptoms associated with vagus nerve dysfunction, such as persistent cough, changes in speech, and difficulty swallowing. The study also found structural changes and thickening in the vagus nerve, as well as observable flattening of the diaphragm, suggesting that damage to the vagus nerve may be responsible for respiratory and other symptoms in Long COVID patients. (Source: Forbes) July 6, 2023 - A study investigated the neural mechanisms underlying the improvement of emotional health in patients with traumatic brain injury (TBI) undergoing repetitive transcranial magnetic stimulation (rTMS) treatment. Using resting-state functional magnetic resonance imaging (fMRI) and spectral dynamic causal modeling (spDCM), the study identified changes in brain effective connectivity, particularly in the dorsal anterior cingulate cortex (dACC), left anterior insula, and medial prefrontal cortex, suggesting potential neural mechanisms for the improvement of emotional health in TBI patients. (Source: Nature) Study Finds Cochlear Implant Surgery Does Not Affect Mastoid Volume Growth in Children July 6, 2023 - A recent study investigated the development of mastoid volume in children who underwent cochlear implantation surgery and found that the mastoid volume increased over time, indicating normal growth. The study also observed linear measurements between anatomical points in the mastoid bone, showing a positive correlation with mastoid volume. The findings suggest that cochlear implant surgery does not impact the natural growth of the mastoid air cell system in children. (Source: Nature) Brain-Spine Interface Shows Promise in Restoring Motor Function in Spinal Cord Injury Patients July 6, 2023 - A Swiss research team has successfully restored standing, walking, and stair-climbing abilities in a 38-year-old man with a cervical spinal cord injury using an implanted brain-spine interface (BSI). The BSI, consisting of implanted electrodes and an artificial intelligence algorithm, captured neural signals from the brain and wirelessly transmitted them to an epidural stimulator targeting the spinal cord, allowing the patient to regain motor control. (Source: Neurology Today) Artificial Intelligence Shows Promise in Enhancing Deep Brain Stimulation for Neurological Disorders July 5, 2023 - Researchers are exploring how artificial intelligence (AI) can improve outcomes in deep brain stimulation (DBS). AI is being investigated for facilitating target localization during electrode placement and optimizing stimulation parameters, with the potential to enhance precision and efficiency in DBS procedures. (Source: Forbes) July 5, 2023 - Transcranial magnetic stimulation (TMS) is highlighted as a potentially effective treatment for depression related to traumatic brain injury (TBI), offering the ability to stimulate or inhibit specific brain circuits that may be overactive or underactive in TBI-related depression, providing a more targeted therapeutic approach. (Source: NBC News) July 5, 2023 - A case report discusses the anesthetic management of a 75-year-old patient with Parkinson's disease (PD) and a deep brain stimulator (DBS) device undergoing urgent hemiarthroplasty surgery, and highlights the considerations and challenges associated with DBS devices in the perioperative period, including electromagnetic interference, medication management, device activation, and postoperative care. (Source: Cureus) New Partnership Explores the Intersection of AI and Neuromodulation for Sleep Disorders July 4, 2023 -Two professors are collaborating to develop electronic devices that can investigate sleep modulation and potentially offer interventions for sleep disorders. By integrating machine learning algorithms into wireless systems-on-chips, the researchers aim to gain a deeper understanding of sleep patterns and disorders and incorporate neural interfacing capabilities to enable precise interventions. The project is supported by a $2.2 million grant from the National Institutes of Health. (Source: University of Toronto Engineering News) Study Investigates COVID-19's Impact on the Brain and Therapeutic Avenues for Long COVID July 4, 2023 - This article explores the detrimental effects of COVID-19 on the brain, highlighting the presence of neurological symptoms in patients with long COVID, including the potential role of Epstein-Barr virus reactivation and changes in the gut microbiome, as well as therapeutic options such as dietary interventions, probiotics, fecal microbiota transplantation, vagus nerve stimulation, and the use of the sigma-1 receptor agonist fluvoxamine. (Source: Nature) July 4, 2023 - This article discusses the ability of vagus nerve stimulation (VNS) to influence brain activity and activate anti-inflammatory pathways, and how VNS has shown promise in epilepsy, depression, and now holds potential for conditions such as rheumatoid arthritis and Crohn's disease. (Source: Scientific American) July 3, 2023 - A triple-blind, randomized, and sham-controlled trial conducted in Germany, known as the DepressionDC trial, investigated the efficacy of transcranial direct current stimulation (tDCS) as an additional treatment to selective serotonin reuptake inhibitors (SSRIs) in adults with major depressive disorder (MDD). The study found that tDCS was not superior to sham stimulation in improving depressive symptoms over a 6-week period, thus not supporting its effectiveness as an adjunct therapy for MDD. (Source: The Lancet) July 3, 2023 - A study conducted by researchers at the Brigham and Women's Hospital has identified a common brain circuit that may link different lesion locations causing epilepsy. By utilizing lesion network mapping, the researchers found that the disrupted brain connections, rather than the specific lesion locations, were key factors associated with epilepsy. The findings provide potential targets for brain stimulation and may have clinical implications for predicting the risk of epilepsy following brain damage. (Source: News Medical) Scientists Discover Brain Region that Triggers Out-of-Body Experiences July 3, 2023 - Scientists have identified a specific area of the brain, known as the anterior precuneus, that when stimulated, can induce out-of-body experiences. The research conducted by Dr. Josef Parvizi and his team at Stanford found that electrically stimulating the anterior precuneus led to changes in participants' sense of their physical self, suggesting the critical role of this brain region in our perception of personal identity and physical presence. (Source: NPR) July 3, 2023 - This article addresses a study on the relationship between sleep deprivation and depression relief. Exploring the neural mechanisms involved, the research may present useful insight into candidate targets for transcranial magnetic stimulation (TMS). (Source: Scientific American) Study Suggests Improved Outcomes for Teens with Cochlear Implants June 30, 2023 - According to a study published in JAMA Otolaryngology-Head & Neck Surgery, adolescents with cochlear implants (CIs) experience improved language skills, academic performance, and quality of life compared to those without CIs, highlighting the importance of early identification and intervention for children with hearing loss. (Source: HealthDay News) Ethical Considerations in Rapid and Novel Treatments Such As Neuromodulation in Psychiatry June 30, 2023 - This article delves into the ethical considerations surrounding rapid and novel treatments in psychiatry, including psychedelics and neuromodulation, focusing on areas such as informed consent, the role of expectancy in clinical response, and distributive justice. The authors emphasize the need for careful navigation and ethical guidelines to address the complexities of these treatments. (Source: Nature) Electrical Stimulation of Vagus Nerve Shows Promise in Reversing Chronic Inflammation June 29, 2023 - Electrical stimulation of the vagus nerve, which controls many autonomic functions in the body, has been found to regulate inflammation and may offer a new treatment approach for chronic inflammatory conditions such as rheumatoid arthritis and Crohn's disease. Clinical trials have shown that vagal nerve stimulation reduces symptoms and inflammation, highlighting the potential of this novel therapeutic approach. (Source: Forbes) Researchers Develop Optogenetics Tool to Study Gut-Brain Connection June 29, 2023 - Scientists have developed a specialized optogenetics tool using long, flexible fibers equipped with electrodes and light emitting devices to stimulate nerve cells in the gut. By using this technology, they were able to mimic behavioral changes associated with brain stimulation, shedding light on the gut-brain connection and its potential involvement in conditions such as Parkinson's disease. (Source: Parkinson’s News Today) Brain-Computer Interface with Sense of Touch Enhances Mobility for Paralyzed Individuals June 28, 2023 - A study published in Science demonstrates the potential of a bidirectional brain-computer interface (BCI) that combines vision and touch to improve the control of robotic limbs by paralyzed individuals. By recording neural activity and evoking tactile sensations through cortical stimulation, the BCI enabled a quadriplegic patient to enhance their performance and achieve task completion times closer to those of able-bodied individuals. (Source: Psychology Today) Chemical Imbalance in Forebrain Linked to Obsessive-Compulsive Disorder June 27, 2023 - Researchers at the University of Cambridge have discovered an imbalance between the neurotransmitters glutamate and GABA in the frontal lobes of individuals with obsessive-compulsive disorder (OCD). The findings suggest a dysregulation of the brain system for controlling habits, providing new insights into the underlying mechanisms of OCD and treatment avenues including deep brain stimulation and transcranial magnetic stimulation. (Source: Science Daily) Brain Activity Patterns in Orbitofrontal Cortex Can Predict Chronic Pain State June 28, 2023 - A recent study has identified a biomarker for chronic pain severity by analyzing brain activity in patients' orbitofrontal cortex (OFC), marking the first objective biomarker for chronic pain. The findings suggest that neuromodulation techniques, such as personalized brain stimulation, could be potential therapies for individuals with refractory chronic pain. (Source: Pain Medicine News) Article Review Addresses The Potential of Closed-Loop Neurostimulation for Psychiatric Disorders June 27, 2023 - Psychiatric diseases pose a significant challenge due to their varied presentation and symptoms, making one-size-fits-all treatments ineffective. Closed-loop neurostimulation, which utilizes biomarkers and device-driven stimulation during symptomatic periods, shows promise in providing personalized therapy for psychiatric disorders. This article reviews the use of open- and closed-loop neurostimulation, particularly deep brain stimulation, as a potential treatment approach and discusses important considerations for implementing closed-loop neurostimulation in the field of neuropsychiatric. (Source: Nature) Revolutionary Nanoelectrode Enables High-Resolution Brain Stimulation with Unprecedented Precision June 26, 2023 - Researchers at Rice University have developed a flexible nanoelectrode that allows for highly precise and discreet brain stimulation. This breakthrough technology offers the potential for finer control over small groups of neurons and long-term implantation without causing tissue damage or scarring. By delivering low-current electrical pulses, the nanoelectrode achieve notable efficacy and paves the way for advanced applications such as brain-machine interfaces and enhanced sensory encoding. (Source: Medgadget) Study Addresses Application of Vagus Nerve Stimulation for Inflammatory Conditions June 23, 2023 - This study suggests that α7nAChR signaling enhances cell-cell interactions in macrophages, resulting in anti-inflammatory effects and organ protection. This research highlights the potential of targeting α7nAChR signaling through vagus nerve stimulation for developing anti-inflammatory strategies for conditions such as acute kidney injury. (Source: Nature) June 23, 2023 - Joe Salazar, a medical student diagnosed with Parkinson's disease at the age of 25, shares his journey of shattered dreams and renewed hope after undergoing a transformative Deep Brain Stimulation (DBS) procedure that significantly improved his quality of life, highlighting the potential benefits of DBS for Parkinson's patients. (Source: People) Article Explores Potential of Brain-Machine Interfaces in Mental Health Treatment June 23, 2023 - Brain-machine interfaces (BMIs) offer a new paradigm for treating mental health disorders, with potential applications including deep brain stimulation (DBS) and non-invasive techniques like transcranial magnetic stimulation (TMS) and electroencephalography (EEG). Recent studies have shown promising results in reducing symptoms of depression and post-traumatic stress disorder (PTSD) using closed-loop BMI systems, highlighting the potential for more targeted and effective interventions in the future. (Source: CityLife)
June 22, 2023 - Article on Carl McLain, a Parkinson's disease patient, who underwent deep brain stimulation (DBS) surgery to alleviate his symptoms. While the treatment does not cure Parkinson's, it helps control symptom fluctuations and provides patients with improved quality of life, allowing them to regain functionality and pursue activities they enjoy. (Source: UT Health) June 22, 2023 - The National Football League (NFL) and the NFL Players Association (NFLPA) are providing research grants to study the effects of non-invasive vagal nerve stimulation (nVNS) on pain management and performance in athletes. These studies aim to investigate the potential benefits of nVNS as an alternative pain management method for NFL players and potentially for athletes in general. (Source: NFL) June 22, 2023 - In a pilot study conducted by researchers at the University of California, Los Angeles, the effectiveness of high-definition cathodal transcranial direct current stimulation (HD C-tDCS) in improving blood flow in acute ischemic stroke patients was evaluated. By applying a weak inhibitory electrical current to the specific area of the brain with low blood flow, this noninvasive stimulation technique demonstrated potential benefits in protecting the penumbra from irreversible damage and enhancing blood flow. (Source: Medical Daily) June 21, 2023 - A recent study published in the Journal of Neuroscience explores the effects of auricular transcutaneous vagus nerve stimulation (atVNS) on working memory (WM) gating dynamics. The study reveals that atVNS specifically modulates the closing of the WM gate, facilitating the maintenance of information in working memory. This modulation is achieved through the modulation of EEG alpha band activity in regions associated with stimulus information, motor response information, and stimulus-response mapping rules. The findings suggest that atVNS enhances the ability to shield information from distraction. (Source: The Journal of Neuroscience) June 19, 2023 - A study on late-life depression patients suggests that repetitive transcranial magnetic stimulation (rTMS) may be effective, with higher remission rates observed in participants with fewer prior medication trials, indicating the potential benefits of early utilization of rTMS in depression treatment. (Source: Cambridge) Robot-Assisted Deep Brain Stimulation Surgery Shows Promise for Treating Epilepsy June 18, 2023 - A neurosurgeon in Canada has successfully performed robot-assisted deep brain stimulation surgery on epilepsy patients, with three surgeries completed since January. The procedure involves implanting electrodes in specific brain areas to restore function and prevent seizures, similar to a pacemaker for the heart. (Source: Interesting Engineering) China Approves Company's Sacral Nerve Stimulation System for Bladder and Bowel Conditions June 16, 2023 - General Stim Inc. has received approval in China for its implanted sacral nerve stimulation (SNS) system, which is used to treat bladder and bowel conditions. The system includes a sacral nerve stimulator, an extension lead, and an electrode. (Source: Bio World) Obstructive Sleep Apnea Common After Vagus Nerve Stimulation Implantation June 16, 2023 - A meta-analysis presented at a sleep medicine conference revealed that obstructive sleep apnea (OSA) is a common adverse event following vagus nerve stimulation (VNS) implantation in patients with intractable epilepsy. The study emphasized the importance of monitoring patients for OSA after VNS treatment. (Source: Pulmonology Advisor) Study Suggests Psychedelic Drugs and Brain Stimulation Show Potential Synergistic Effect June 16, 2023 - New research published in the journal Psychedelic Medicine suggests that psychedelic drugs, such as LSD, can alter the effects of brain stimulation, leading to potentially larger changes in brain activity. The study highlights the possibility of using a combination of psychedelic drugs and brain stimulation, such as TMS, as an innovative approach for treating various conditions, although further research is needed to explore the long-term effects and behavioral changes associated with this approach. (Source: PsyPost) Article Explores Potential of Neuromodulation in Treating Anorexia Nervosa and Bulimia June 16, 2023 - Repetitive transcranial magnetic stimulation (rTMS) and deep brain stimulation (DBS) are being investigated as potential treatments for anorexia nervosa and bulimia nervosa, with promising but limited findings. (Source: Psychiatric Times) Implanted Brain-Spine Interface Restores Standing and Walking Ability in Man with Spinal Cord Injury June 15, 2023 - A Swiss team has successfully enabled a 38-year-old man with a cervical spinal cord injury to regain the ability to stand and walk using an implanted brain-spine interface (BSI). The BSI captured neural signals from the sensorimotor cortex and wirelessly transmitted them to an epidural stimulator, allowing the man to control his leg muscles and perform movements with the aid of an artificial intelligence algorithm. Further research with additional participants is planned. (Source: Neurology Today) Study Explores Core Elements of Accelerated TMS for Rapid Treatment of Depression June 15, 2023 - A recent review article in Neuropsychopharmacology explores the core elements of accelerated transcranial magnetic stimulation (TMS) for the treatment of major depressive disorder (MDD). The authors highlight various categories, including treatment parameters, cumulative exposure, individualized parameters, and brain state. (Source: Psychiatric Times) News Broadcast Addresses Brain Implant Industry and Its Medical Possibilities June 14, 2023 - Academics from the Center for Neurotechnology at the University of Washington and the department of Medical Ethics and Health Policy at the University of Pennsylvania speak alongside the Chief Commercial Officer of Synchron about the brain implant industry and its medical possibilities. (Source: 1A WAMU NPR) June 13, 2023 - A recent six-month post hoc follow-up study examined the efficacy of spinal cord burst stimulation in patients with chronic radicular pain after lumbar spine surgery. The study concluded that burst stimulation was not superior to placebo in improving pain-related disability, highlighting the limitations of blinding treatment allocation and the inability to fine-tune stimulation parameters in the original trial. (Source: JAMA Network) FDA Clears Company's OCD Motor Threshold Cap for Transcranial Magnetic Stimulation System June 13, 2023 - The FDA has granted 510(k) clearance to Neuronetics for its obsessive-compulsive disorder (OCD) motor threshold cap technology, an addition to the NeuroStar transcranial magnetic stimulation system. The cap streamlines the treatment process by providing a consistent starting location and mapping process, reducing the time and steps involved in coil placement, and aims to enhance treatment efficiency and personalized care for individuals with OCD. (Source: Healio) June 13, 2023 - A literature review reveals significant advancements in deep brain stimulation (DBS) for movement disorders, leading to improved clinical outcomes and offering promising avenues for future research and development. (Source: Cureus) Breakthrough Research on Dissolvable Coatings Paves the Way for Implantable Treatments for Epilepsy June 12, 2023 - University of Glasgow researchers have made significant progress in developing dissolvable coatings for flexible neural probes used in the treatment of temporal lobe epilepsy. The novel materials offer improved compatibility with brain tissue, reducing the risk of scarring and enabling more effective placement of the probes, bringing the possibility of a cure for epilepsy closer to reality. (Source: Phys.org) TMS Investigated as Potential Treatment for Eating Disorders in Novel Research Program June 12, 2023 - Monash University's Li Transformative Hub for Research in Eating Disorders (THRED) aims to explore biological causes and treatments for eating disorders, including the investigation of transcranial magnetic stimulation (TMS) to potentially "re-program" the brains of individuals with eating disorders, as part of a multi-faceted approach to improving treatment outcomes. (Source: Monash University) Advances in Brain-Spine Interfaces Hold Promise for Movement Restoration after Spinal Cord Injuries June 12, 2023 - Brain-spine interface technology advances to restore movement in individuals with lower body motor impairments caused by spinal cord injuries. A digital bridge translates neural signals, enabling brain-driven muscle movement and offers promising progress in motor function restoration. (Source: Forbes) Medtronic Warns of Potential Damage to Vanta Neurostimulators During Cardioversion Therapy June 12, 2023 - Medtronic has issued a field safety notice warning neurosurgeons that one of the models in its Vanta range of implantable neurostimulators may become unresponsive and non-functional if patients undergo cardioversion therapy for heart rhythm restoration. The notice advises temporary reprogramming of the device during the procedure to mitigate the risk and highlights updated manuals and labeling to enhance patient awareness and reduce potential damage. (Source: Fierce Biotech) June 12, 2023 - Young adults who engaged in heavy alcohol consumption during their teenage years exhibited reduced cortical gray matter thickness and modified neurotransmission, specifically increased N45 potential, highlighting the detrimental impact of adolescent heavy drinking on adult brain structure and function. MRI and simultaneous TMS-EEG were leveraged to measure gray matter changes. (Source: Neuroscience News) Article Addresses Addition of Spinal Cord Stimulation to Nebraska Hospital June 11, 2023 - A physician has introduced spinal cord stimulation to the in-house practices of Methodist Physicians Clinic in Nebraska, and advocates for the importance of a collaborative approach to pain management, including physical medicine and rehabilitation, primary care physicians, physical therapists, neurosurgeons, and orthopedic surgeons to provide quality patient care. (Source: Omaha World-Herald) New Mouse Model Reveals Role of Zinc in Neuromodulation June 9, 2023 - The development of a new mouse model could lead to new insights into the role of zinc in neuromodulation and to the development of new treatments for neurological disorders. (Source: Science) SO-tDCS Improves Memory Consolidation During Restricted Sleep June 8, 2023 - A study finds slow oscillatory transcranial direct current stimulation (SO-tDCS) improved memory consolidation in healthy patients during restricted nighttime sleep. (Source: Neurology Live) Neuromodulation Offers New Treatment Option for Obstructive Sleep Apnea June 7, 2023 - Upper airway stimulation therapy, which is delivered by stimulating the hypoglossal nerve, uses electrical stimulation to treat obstructive sleep apnea and has been proposed as an effective alternative for those who are unable to tolerate a CPAP. (Source: Mayo Clinic Health System) Spinal Cord Stimulation Shows Promise in Helping Paraplegic Patients Walk Again June 7, 2023 - A clinical trial of 20 patients at Hennepin Healthcare in Minneapolis has found that spinal cord stimulation can help paraplegic patients regain some movement in their legs. After receiving the implant, patients reported improvements in movement, mobility, blood circulation, and bowel and bladder control. (Source: Kare11 News) Transcranial Magnetic Stimulation Shows Promise in Helping Smokers Quit June 7, 2023 - A recent study found that repetitive TMS was effective in helping smokers quit, with a quit rate of 28% after 12 weeks. (Source: Nature) Deep Brain Stimulation Study Finds Brain Activity Patterns Can Predict Chronic Pain June 6, 2023 - Researchers have identified brain activity patterns that are associated with chronic pain in a study with four participants. They also studied deep brain stimulation (DBS) as a potential treatment for chronic pain, but more research is needed to confirm its effectiveness. (Source: National Institutes of Health) University Researchers Use Vagus Nerve Stimulation to Treat Hypermobile Ehlers-Danlos Syndrome June 6, 2023 - A team of researchers at MUSC has received a Blue Sky Award to investigate the use of vagus nerve stimulation (VNS) to treat hypermobile Ehlers-Danlos syndrome (hEDS). This award is granted to potentially high-value research projects that are unlikely to receive traditional funding. (Source: Medical University of South Carolina) Study Finds Obstructive Sleep Apnea Common Side Effect of Vagus Nerve Stimulation June 5, 2023 - A study found that 27.3% of patients who received vagus nerve stimulation (VNS) for epilepsy or depression developed obstructive sleep apnea (OSA). The study's authors recommend that neurosurgeons screen patients for OSA before and after VNS implantation. (Source: Neurology Live) Study Finds Targeted Deep-Brain Stimulation During Sleep Can Enhance Memory Consolidation June 2, 2023 - A study by researchers at UCLA and Tel Aviv University finds targeted deep-brain stimulation (DBS), when performed during a specific sleep phase, can enhance memory consolidation. The study, which was published in the journal Nature Neuroscience, could provide new insights into how DBS could potentially treat memory disorders such as Alzheimer's disease. (Source: Neuroscience News) Study Finds Spinal Cord Stimulation Can Help Paralyzed Patients Regain Function June 2, 2023 - A clinical trial at HCMC in Minneapolis is showing that spinal cord stimulation can help paralyzed patients regain function, even if they have been injured for many years. The study is still ongoing, but the early results are varied yet promising. (Source: StarTribune) Study suggests Vagus Nerve Stimulation During Sleep May Improve Memory June 2, 2023 - A study published in Nature Neuroscience found that deep brain stimulation during sleep during non-REM sleep improved memory in people with severe epilepsy. The researchers believe that this approach could be used to improve memory in people with other conditions, such as Alzheimer's disease. (Source: NPR) June 2, 2023 - A recent observational cohort study comparing treatment options for pediatric patients with drug-resistant epilepsy found that those who underwent cranial epilepsy surgery or received vagus nerve stimulation (VNS) had higher survival rates compared to those who received only medical treatment. (Source: The Lancet) June 2, 2023 - Researchers at the University of Rochester used neurostimulation during critical developmental windows to target underperforming dopamine neurons in mice, leading to long-lasting changes that corrected structural brain deficiencies associated with neuropsychiatric disorders like schizophrenia and autism. This suggests the potential for interventions during specific developmental periods to alter the course of these disorders. (Source: Neuroscience News) Study Reveals Brain's Memory Consolidation Process During Sleep June 1, 2023 - New research demonstrates how the brain consolidates memories during sleep by stimulating specific brain regions. The study's brain stimulation technique shows potential for future advancements in memory research and therapeutic interventions. (Source: USA Today) Computational Models Predict Vagus Nerve Stimulation Thresholds in Preclinical Animals and Humans May 31, 2023 - Validated computational models, utilizing ASCENT software, accurately simulate the effects of vagus nerve stimulation (VNS) in humans, pigs, and rats. The models incorporate various factors such as nerve histology, device design, tissue conductivities, and realistic fiber models, successfully predicting activation thresholds for different species and fiber types. The study highlights the potential of these models in understanding the therapeutic and side effects of VNS and individual-specific variations in neural responses. (Source: IOP Science) May 31, 2023 - In an interview, Dr. Cornelia Drees, a senior associate consultant in the Department of Neurology at Mayo Clinic, highlights the potential of microburst vagus nerve stimulation (VNS) as a targeted treatment for drug-resistant epilepsy. Microburst VNS differs from traditional VNS by delivering stimulation at higher frequencies in short bursts, showing promising results in reducing seizure frequency and improving quality of life in patients. (Source: NeurologyLive) Engineers Develop Flexible Nanoelectrodes for Fine-Grained Brain Stimulation May 30, 2023 - Rice University engineers have created ultraflexible nanoelectrodes that can be implanted in the brain for long-term, high-resolution stimulation therapy. The devices exhibit high biocompatibility and precise control over stimulus patterns, offering potential for sensory prostheses and improved treatment for conditions such as Parkinson's disease, epilepsy, and obsessive-compulsive disorder (OCD). (Source: Science News) Nerve Stimulation Shows Promise in Tobacco De-addiction May 30, 2023 - Dr. M.S. Reddy, a psychiatrist, has introduced a non-invasive neuromodulation treatment using deep transcranial magnetic stimulation (TMS) to help tobacco users quit their addiction. The treatment has shown success in 27 out of 60 patients, with others significantly reducing tobacco use. (Source: Deccan Chronicle) May 29, 2023 - In a conversation with journalist Rose Eveleth, former editor of IEEE Spectrum, Sally Adee, discusses the potential implications of transcranial direct current stimulation (tDCS) technology. Adee touches upon concerns about the democratization of tDCS, the risks of self-experimentation, the limited understanding of its efficacy, the ethical considerations in sports and the workplace, and the need to approach emerging bioelectricity research, including tDCS, with clear eyes, avoiding the tendency to fit it into pre-existing narratives. (Source: Bulletin of the Atomic Scientists) May 29, 2023 - The FDA has granted clearance to Neuspera's micro-implant neurostimulation system, making it the first ultra-miniaturized peripheral nerve stimulation device approved for treating chronic peripheral nerve pain. The wireless platform, including a wearable transmitter and iPad-based clinician programmer, offers improved patient experience and procedural flexibility, allowing physicians to target deeper anatomical sites for pain relief. (Source: Pain Medicine News) Wireless Brain-Computer Interface Enables Thought-Controlled Movement in Spinal Cord Injury Patients May 27, 2023 - A study in Nature demonstrates the potential of a wireless brain-computer interface (BCI) paired with ARC Therapy to restore thought-controlled movement in individuals with spinal cord injury (SCI). The BCI establishes a continuous link between movement intentions and spinal cord stimulation, allowing for more natural mobility restoration. The ongoing clinical feasibility study shows promising safety and preliminary effectiveness in brain-controlled spinal cord stimulation after SCI. (Source: News Medical) Analysis of Brain Stimulation Studies Explores Efficacy in Enhancing Memory and Focus May 26, 2023 - A comprehensive analysis of over 100 studies on transcranial alternating current stimulation (tACS) and, suggests that these methods can lead to moderate improvements in attention, memory, problem-solving, and other cognitive processes. However, some researchers argue that the diverse nature of the studies makes it difficult to draw definitive conclusions. (Source: Nature) Deep Brain Stimulation of Anterior Nucleus of the Thalamus Shows Efficacy in Drug-Resistant Epilepsy May 26, 2023 - A study published in Neurology presents the results of the Medtronic Registry for Epilepsy (MORE), which assessed the safety and effectiveness of deep brain stimulation (DBS) of the anterior nucleus of the thalamus (ANT) in patients with drug-resistant epilepsy. The study showed a significant reduction in seizure frequency and a responder rate consistent with previous clinical trials. However, adverse events such as changes in seizure patterns, memory impairment, and depressive mood were reported, underscoring the need for careful monitoring during DBS therapy. (Source: Physicians Weekly) Neuralink Receives FDA Approval for First In-Human Clinical Study of Brain Implant Technology May 26 2023 - Neuralink, Elon Musk's neurotech startup, has gained FDA approval for its first in-human clinical study, allowing it to move forward with testing its brain implant called the Link, which aims to help patients with severe paralysis control external technologies using neural signals. (Source: CNBC) May 24, 2023 - As featured in Nature, researchers developed a brain-spine interface (BSI) that restored communication between the brain and the spinal cord in a person with chronic tetraplegia, allowing them to stand and walk naturally. The BSI, which consists of implanted recording and stimulation systems, facilitated control over leg movements and improved neurological recovery, offering a framework for restoring movement in individuals with paralysis. (Source: Science) Head-Worn Device Utilizes Machine Learning and Brain Imaging to Differentiate Hand Gestures May 23, 2023 - Researchers at the University of California San Diego have developed a head-worn wearable device that uses machine learning and magnetoencephalography (MEG) to differentiate hand gestures. The device achieved over 85% accuracy in distinguishing gestures in a trial. This technology has the potential to assist individuals with paralysis or amputated limbs in controlling devices using their minds. (Source: Health IT Analytics) Breakthrough in Decoding Brain Signals Reveals Objective Biomarker for Chronic Pain May 22, 2023 - For individuals with intractable chronic pain, researchers have successfully decoded brain activity underlying chronic pain for the first time. The findings may have an impact on deep brain stimulation clinical trials. The study identified brain regions associated with pain and developed an algorithm to predict pain levels based on electrical signals in the brain, which may provide opportunity for personalized therapies. (Source: Guardian) Study Addresses Accelerated TMS for Faster Relief of Depression Symptoms May 22, 2023 - Accelerated transcranial magnetic stimulation (TMS) protocols have shown potential for reducing treatment duration and improving response time in major depressive disorder (MDD). This study reviews nine elements around accelerated TMS including treatment parameters, cumulative exposure, individualized parameters, and brain state. (Source: Nature) Vagal Nerve Stimulation Explored as Potential Treatment for New-Onset Refractory Status Epilepticus May 21, 2023 - Researchers propose the consideration of vagal nerve stimulation (VNS) as a well-tolerated intervention for new-onset refractory status epilepticus (NORSE). Although limited evidence exists, VNS shows potential in reducing seizure burden and modulating ictogenesis, highlighting the need for further investigation through clinical trials. (Source: AJMC) May 19, 2023 - A prospective study of 73 adults conducted in Vietnam compared deep brain stimulation (DBS) surgery to medical therapy in patients with advanced Parkinson's disease (PD). The study found that DBS was more cost-effective and improved motor function, reducing "off" time and dyskinesia in patients. (Source: Healio) Stanford Study Reveals How Transcranial Magnetic Stimulation Treats Depression May 18, 2023 - A Stanford study has found that transcranial magnetic stimulation (TMS) treats depression by reversing the direction of abnormal brain signals. Backward streams of neural activity between specific areas of the brain were highlighted as a potential biomarker to diagnose depression. (Source: Neurology Live) Article Shares First Person Experience in Study for Spinal Cord Injury Recovery May 18, 2023 - An news story covers a news anchor who is part of a research study at the University of Louisville. The study uses epidural stimulation to help individuals with spinal cord injuries regain muscle control and independence, showing promising progress in the patient’s ability to stand and improve mobility. (Source: WISN) Tactile Stimulation at 40 Hz Frequency Shows Promise in Alzheimer's Treatment May 18, 2023 - Researchers have found that daily exposure to tactile stimulation at a frequency of 40 Hz can reduce Alzheimer's disease pathology and improve motor function. The study conducted on Alzheimer's model mice demonstrated a decrease in phosphorylated tau levels, protection against neuronal damage and synaptic loss. This discovery suggests the potential for non-invasive therapeutic strategies in treating neurodegenerative diseases like Alzheimer's. (Source: Neuroscience News) FDA Approves Spinal Cord Stimulation Devices for Non-Surgical Back Pain May 16, 2023 - Abbott received FDA approval for its entire portfolio of spinal cord stimulation (SCS) devices for patients with chronic back pain who have not had or are ineligible for surgery. This approval includes the recharge-free Proclaim SCS family and the rechargeable Eterna SCS platform. (Source: MassDevice) First-in-Human Use for Spinal Cord Injury Patients Shows Promising Results May 15, 2023 - ONWARD Medical has achieved a successful first-in-human use of their ARC-IM Lead, delivering targeted electrical pulses to the spinal cord. The lead's unique design and electrode placement offer potential benefits for blood pressure regulation in individuals with spinal cord injury. (Source: Yahoo Finance) Smart Earpiece May Accelerate Stroke Recovery by Stimulating Neural Circuits May 15, 2023 - Researchers from ETH Zurich have developed a smart earpiece that stimulates the vagus nerve to accelerate stroke recovery. The non-invasive system eliminates the need for surgery and promotes neuroplasticity by timing electrical impulses during specific motor actions. A movement sensor tracks progress, and remote monitoring is possible via a smartphone app. The first clinical study is impending. (Source: Today’s Medical Developments) May 12, 2023 - This study targets parasympathetic modulation via non-invasive transcutaneous auricular vagal nerve stimulation (ta-VNS) and suggests that this procedure is promising as a treatment or supplementary treatment for polycystic ovary syndrome (PCOS). (Source: Nature) Study Indicates PET Imaging Reveals Brain Stimulation's Effects in Coma Patients May 11, 2023 - A study utilizing PET imaging has shown that trigeminal nerve stimulation (TNS) can increase brain metabolism in key cognitive areas and potentially promote recovery in patients with disorders of consciousness. The findings support the use of TNS as a promising intervention for coma awakening and demonstrate the effectiveness of FDG-PET as an objective evaluation tool in assessing brain function in these patients (Source: Brain Stimulation) Spinal Cord Stimulation System Receives Expanded FDA Approval for MRI Labeling May 11, 2023 - Abbott has received expanded FDA MRI labeling for its Eterna pain relief device. (Source: Seeking Alpha) Implantable Tibial Neuromodulation Therapy for Overactive Bladder Shows Promising Results May 10, 2023 - OASIS, a 151-patient open-label clinical study demonstrated statistically significant improvement in reduction in urgency urinary incontinence, including urinary urgency and urinary frequency. Results are under review by the FDA. (Source: Yahoo! Finance) Survey of Parkinson’s Patients Indicated Deep Brain Stimulation Knowledge Gaps April 27, 2023 - A survey of 52 adults with Parkinson’s Disease revealed knowledge gaps about deep brain stimulation use, including side effects, symptom management, and whether it alters the course of the disease. Improvements in patient education and counseling were recommended. (Source: Healio) April 27, 2023 - Findings from a study in rats suggest that spinal cord stimulation may be a promising treatment to reduce peripheral neuropathy and associated pain in cancer patients undergoing active treatment with paclitaxel, a common anti-cancer drug. (Source: Science Direct) Study Finds External Brain Stimulation Can Condition Brain Activity April 24, 2023 - A study with 75 participants found that the effects of transcranial magnetic stimulation (TMS) can be triggered by listening to a tone. While TMS effects are generally temporary, classical conditioning through TMS may be useful to extend the effects in various therapeutic applications (Source: Neuroscience News) Spinal Cord Stimulation System Receives Expanded FDA Approval for MRI Labeling April 19, 2023 - Neuspera Medical received FDA clearance for its novel implantable spinal cord stimulation system. (Source: Seeking Alpha) Study Shows Epidural Stimulation Can Help People With Spinal Cord Injuries Regain Ability to Walk April 19, 2023 - A study has found that epidural stimulation can help people with spinal cord injuries (SCI) regain the ability to walk. All six participants received epidural stimulation and underwent rehabilitation and experienced significant improvements in their walking ability and overall mobility. (Source: Neuroscience News) Apr. 19, 2023 - The FDA has granted approval to Biotronik's spinal cord stimulation system (SCS), called Prospera, for pain relief. The device, which uses both burst and tonic stimulation, is intended for the treatment of chronic pain in the back and legs. (Source: MassDevice) Apr. 16, 2023 - Spinal cord stimulation (SCS) may be an intervention to mitigate unstable blood pressure following spinal cord injury (SCI). Results of this case series show promising evidence to support epidural SCS to prevent autonomic dysreflexia (AD) episodes during routine bowel procedures. (Source: MDPI) Apr. 14, 2023 - This article addresses that the impact of transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) on the blood brain barrier may increase the effectiveness of neuromodulation in Alzheimer’s patients and calls for further investigation. (Source: Nature) Apr. 14, 2023 - A systematic review of 38 randomised controlled trials (RCTs) was featured in Neuromodulation: Technology at the Neural Interface. Findings indicate transcutaneous vagus nerve stimulation (VNS) and transcranial direct current stimulation (tDCS) were effective in improving upper-limb motor function. (Source: NeuroNews International) Spinal Cord Stimulator Gains FDA Approval After Restoring Arm Movement After Stroke Apr. 12, 2023 - Reach Neuro was granted a breakthrough-device designation by the FDA after the device restored arm movement for two patients following partial paralysis after stroke. Patients experienced improved strength, speed, and functionality. (Source: Fierce Biotech) Apr. 11, 2023 - The first patient was enrolled in a randomized, prospective, multicenter clinical trial to assess the safety and efficacy of ExaStim® Therapy, a non-invasive spinal stimulator in treating spinal cord injury. (Source: Yahoo! Finance) Experimental Device May Support Low Blood Pressure Due to Spinal Cord Injury Apr. 10, 2023 - A neuroprosthetic baroflex is an experimental device that stimulates the neurons in the lower lower part of the spine that are involved in blood pressure control. A recent essay in Science suggests this device may notably increase blood pressure and restore hemodynamic stability (Source: HealthDay) Company Receives Full FDA Approval for Diaphragm Stimulation System Apr. 6, 2023 - The NeuRx diaphragm stimulation solution has premarket approval from the FDA to help hospitalized patients with spinal cord injuries to breathe more naturally than with a ventilator. This system also has a humanitarian use exemption from the FDA to provide breathing support for people with amyotrophic lateral sclerosis. (Source: Fierce Biotech) Apr. 4, 2023 - The American Society of Regional Anesthesia and Pain Medicine approved the formation of a steering committee to develop evidence-based guidelines for patient selection and the role of a spinal cord stimulation trial. The results were published in the Regional Anesthesia & Pain Medicine journal. (Source: Newswise) Mar. 28, 2023 - An article on chronic pain addresses the gap between pain management research and clinical application, as well as the search for biomarkers for pain, psychological implications, and recent research findings. One patient’s experience with intrathecal drug delivery and spinal cord stimulation is also mentioned, among other treatment methods. (Source: Nature) Mar. 20, 2023 - This study reports on the long-term efficacy and safety of spinal cord stimulation (SCS) as a treatment option for refractory angina pectoris (RAP). Results after a one-year follow-up showed reductions in angina frequency and use of short-acting nitrates, with a low risk of spinal cord stimulator-related complications. (Source: Science Direct) Mar. 16, 2023 - An American Journal of Psychiatry study of treatment-resistant depressed patients reported widespread acute alterations in functional connectivity beyond the targeted cortical area after one rTMS (repetitive transcranial magnetic stimulation) session. Patients with the most pronounced connectivity changes in session one tended to get more benefit from a 4-week course of therapy. (Source: Brain & Behavior Research Foundation) Depression Severity was Decoded from Intracranial Neural Activity in a Recent Study Mar. 16, 2023 - In a study published in Biological Psychiatry, intracranial electrodes were implanted in the prefrontal cortical regions in three human subjects with severe depression and depression severity scores were taken from neural recordings. Reduced depression severity was associated with decreased low-frequency neural activity and increased high-frequency activity. (Source: Neuroscience News) Mar. 15, 2023 - A study of 29 children diagnosed with cochlear nerve deficiency (CND) who underwent cochlear implantation found a significant correlation between electrically evoked compound action potential (ECAP) thresholds and behavioral-T levels. The results can more efficiently inform the selection of stimulation levels for children who cannot cooperate with behavioral testing. (Source: Scientific Reports) Neurostimulation and Neuromodulation Offer New Approaches to Treat Dry Eye Mar. 7, 2023 - Devices and pharmaceuticals that stimulate the trigeminal nerve have been found to produce real tears that provide relief for ocular surface disease. (Source: Healio) Company’s FDA Clearance is Expanded for Neuromodulation Armband for Migraine Mar. 1, 2023 - The Nerivio neuromodulation armband is available by prescription to treat migraine symptoms after onset, and newly expanded FDA clearance approved the device for migraine prevention. (Source: Fierce Biotech) Study Details Early Vagus Nerve Mapping and Novel Vagus Nerve Stimulation Device Feb. 28, 2023 - Researchers at the Feinstein Institutes for Medical Research published findings in the journal Brain Stimulation after microscopically mapping more than 100,000 fibers that comprise the vagus nerve. The study addresses how they are connected and what bodily functions they control, and insight into a vagus nerve stimulation (VNS) device that can actively target these fibers. (Source: Neuronews International) Article Summarizes Spinal Cord Stimulation Study of Stroke Patients with Upper-Limb Paresis Feb. 20, 2023 - NPR summarizes the publication of a four-week study in Nature Medicine which reports that cervical spinal cord stimulation improved arm and hand movement for two participants with limb paresis years after stroke. The article features the experience of one study participant and the medical team who conducted the study. (Source: NPR) First-Person Article Details Impact of Deep Brain Stimulation for Parkinson’s Feb. 20, 2023 - CBC News New Brunswick host Harry Forestell addresses how deep brain stimulation (DBS) can improve motor function control in some Parkinson’s patients and shares his first-person experience with the procedure, along with a video that demonstrates its effects. (Source: CBC News) News Column Addresses Bioelectricity and Numerous Applications in Neuromodulation Feb. 5, 2023 - A column about bioelectricity describes transcranial direct current stimulation (tDCS), deep-brain stimulation (DBS), and other potential therapeutic and elective implications of bioelectricity in neuromodulation. (Source: The Guardian) Video Features Deep Brain Stimulation Patients for Movement Disorders Feb. 5, 2023 - 60 Minutes Australia featured patients with Parkinson’s and essential tremor (ET) before and after their experience receiving deep brain stimulation (DBS), and addressed the procedure’s potential benefit for a range of movement disorders and other conditions. (Source: 60 Minutes Australia) Company’s Sacral Neuromodulation System Received FDA Approval for Incontinence Jan. 31, 2023 - Axonics’ received FDA approval for its fourth-generation R20 rechargeable sacral neuromodulation system for patients suffering from overactive bladder or fecal incontinence. (Source: MassDevice) Company’s Spinal Cord Stimulation System Received FDA Approval for Diabetic Peripheral Neuropathy Jan. 30, 2023 - Abbott’s Proclaim XR spinal cord stimulation (SCS) received FDA clearance for patients to receive low doses of stimulation for diabetic peripheral neuropathy (DPN) symptoms contributing to chronic pain. (Source: Pharmacy Times) Nerve Stimulation Therapy After Spinal Cord Injury Shows Promise in Animal Studies Jan. 30, 2023 - Columbia University Vagelos College of Physicians and Surgeons published study findings in the journalBrainthat show promise in animals. If applicable in humans, patients with arm function impairment due to spinal cord injury could regain function as a result of the spinal cord associative plasticity (SCAP) technique. (Source: Technology Networks) Company Received FDA Clearance for First Neuromodulation Device to Treat Tinnitus Jan. 30, 2023 - Neuromod Devices’ neurostimulation system for tinnitus – Lenire – received initial FDA clearance. The system takes a two-pronged approach using tones to activate the auditory nerve and mild electrical stimulation of the tongue. (Source: Fierce Biotech) Article Addresses Spinal Cord Stimulation for Sleep and Chronic Pain Jan. 30, 2023 - Senior author Julie Pilitsis, M.D., Ph.D., and a team of researchers at Schmidt College of Medicine published a study in Stereotactic and Functional Neurosurgery which established minimally clinical important difference ranges for the insomnia severity index, a tool established to explore the relationship between insomnia and pain. This study revealed associations between sleep and depression but no correlation between sleep and spinal cord stimulation (Source: Florida Atlantic University) Article Addresses How fMRI Technology May Help Inform Brain Stimulation Jan. 27, 2023 - Ultrafast fMRI can now capture brain activity at sub-second levels which allows for real-time brain monitoring under simulation conditions. Associate Professor Kai-Hsiang Chuang’s laboratory at the Queensland Brain Institute (QBI) found that brain activity is dependent on one’s state, and that blood signal detected by fMRI may reflect network organization and cell type distribution. (Source: Neuroscience News) Transcutaneous Auricular Vagus Nerve Stimulation Can Improve Mild Cognitive Impairment Jan. 27, 2023 - A double blind randomized controlled trial published in Brain Stimulation showed transcutaneous auricular vagus nerve stimulation can improve cognitive performance in patients with mild cognitive impairment (MCI). Evidence shows this technique could prevent or prolong MCI’s development into dementia. (Source: NeuroNews International) |